Literature DB >> 19946336

JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling.

J Bai1, J Zhang, J Wu, L Shen, J Zeng, J Ding, Y Wu, Z Gong, A Li, S Xu, J Zhou, G Li.   

Abstract

JWA, a newly identified novel microtubule-associated protein (MAP), was recently demonstrated to be indispensable for the rearrangement of actin cytoskeleton and activation of MAPK cascades induced by arsenic trioxide (As(2)O(3)) and phorbol ester (PMA). JWA depletion blocked the inhibitory effect of As(2)O(3) on HeLa cell migration, but enhanced cell migration after PMA treatment. As cancer cell migration is a hallmark of tumor metastasis and the functional role of JWA in cancer metastasis is not understood, here we show that JWA has an important role in melanoma metastasis. Our data demonstrated that JWA knockdown increased the adhesion and invasion abilities of melanoma cells. Furthermore, JWA knockdown in B16-F10 and A375 melanoma cells significantly promoted the formation and growth of metastatic colonies in vivo. Moreover, in the tumor biopsies from human melanoma patients, JWA expression was significantly decreased in malignant melanoma compared with normal nevi. In addition, we found that JWA knockdown could intensify tumor integrin alpha(V)beta(3) signaling by regulating nuclear factor Sp1. These findings suggest that JWA suppresses melanoma metastasis and may serve a potential therapeutic target for human melanoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946336     DOI: 10.1038/onc.2009.408

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.

Authors:  Jin Bai; Peng-Jin Mei; Hui Liu; Chen Li; Wang Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

2.  RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.

Authors:  Peng-Jin Mei; Jin Bai; Hui Liu; Chen Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-16       Impact factor: 4.553

3.  RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.

Authors:  Jin Bai; Hong-Mei Yong; Fei-Fei Chen; Wen-Bo Song; Chen Li; Hui Liu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-04       Impact factor: 4.553

4.  Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation.

Authors:  Sha Sha; Jin Xu; Zi-Hong Lu; Juan Hong; Wei-Jun Qu; Jian-Wei Zhou; Ling Chen
Journal:  Mol Neurobiol       Date:  2014-11-30       Impact factor: 5.590

5.  PinX1 inhibits cell proliferation, migration and invasion in glioma cells.

Authors:  Peng-Jin Mei; Yan-Su Chen; Ying Du; Jin Bai; Jun-Nian Zheng
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

6.  Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.

Authors:  Jodi A McKenzie; Tong Liu; Agnessa G Goodson; Douglas Grossman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

7.  Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer.

Authors:  Weimin Wang; Yansu Chen; Jianliang Deng; Jianping Zhou; Xiancheng Gu; Yuehua Tang; Guoqiang Zhang; Yongfei Tan; Zhijun Ge; Yulin Huang; Shouyu Wang; Jianwei Zhou; Yan Zhou; Sujun Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-05       Impact factor: 4.553

8.  JWA deficiency induces malignant transformation of murine embryonic fibroblast cells.

Authors:  Hong Qi; Aiping Li
Journal:  Exp Ther Med       Date:  2018-01-03       Impact factor: 2.447

9.  High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.

Authors:  Yansu Chen; Xiaowei Xia; Shouyu Wang; Xuming Wu; Jianbing Zhang; Yan Zhou; Yongfei Tan; Song He; Fulin Qiang; Aiping Li; Oluf Dimitri Røe; Jianwei Zhou
Journal:  J Gastroenterol       Date:  2013-01-11       Impact factor: 7.527

10.  Survivin promotion of melanoma metastasis requires upregulation of α5 integrin.

Authors:  Jodi A McKenzie; Tong Liu; Jae Y Jung; Benjamin B Jones; Huseyin A Ekiz; Alana L Welm; Douglas Grossman
Journal:  Carcinogenesis       Date:  2013-05-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.